Literature DB >> 18855280

[Comparative study of refractive errors in simple congenital myogenic ptosis and control children].

M A Pérez-Iñigo1, I González, F Mayoral, C Ferrer, F M Honrubia.   

Abstract

PURPOSE: To study refractive errors in children with relatively serious congenital myogenic ptosis and to carry out a comparative study in relation to control children in our population.
METHODS: We included 35 children with simple congenital myogenic ptosis, 27 of them had minor ptosis, 3 moderate ptosis and 5 serious ptosis. Thirty-five children were also in the control group. One eye of every subject was included, the worst eye in subjects of the ptosis group and an eye selected at random in control group subjects. A comparative study of refractive data in every group was carried out, using the Student's t-test, ANOVA and Chi square or Yates correction tests.
RESULTS: We obtained significant differences between children with ptosis and controls in average spherical equivalent (3.08/1.49), in average absolute sphere (2.80/1.42) and in average absolute cylinder (0.81/0.31) (p<0.05). We also observed a relation between the presence of astigmatism and the seriousness of ptosis (chi2=6.88>5.99), and between the need for optical correction and the presence of ptosis (chi2=15.92>3.84).
CONCLUSIONS: Children with simple congenital myogenic ptosis in our enviroment have greater refractive errors than control children. Ptosis children require optical correction more frequently than control. The more serious the ptosis, the more likelihood there is of having astigmatism.

Entities:  

Mesh:

Year:  2008        PMID: 18855280     DOI: 10.4321/s0365-66912008001000007

Source DB:  PubMed          Journal:  Arch Soc Esp Oftalmol        ISSN: 0365-6691


  1 in total

1.  Alterations in corneal epithelial thickness in patients with congenital myogenic eyelid ptosis.

Authors:  Aysun Sanal Dogan; Mutlu Acar; Mustafa Kosker; Nese Arslan; Canan Gurdal
Journal:  Int Ophthalmol       Date:  2016-12-26       Impact factor: 2.031

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.